MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2 (2024)

Abstract

Gradual occlusion of coronary arteries may result in reversible loss of cardiomyocyte function (hibernating myocardium), which is amenable to therapeutic neovascularization. The role of myocardin-related transcription factors (MRTFs) co-activating serum response factor (SRF) in this process is largely unknown. Here we show that forced MRTF-A expression induces CCN1 and CCN2 to promote capillary proliferation and pericyte recruitment, respectively. We demonstrate that, upon G-actin binding, thymosin ß4 (Tß4), induces MRTF translocation to the nucleus, SRF-activation and CCN1/2 transcription. In a murine ischaemic hindlimb model, MRTF-A or Tß4 promotes neovascularization, whereas loss of MRTF-A/B or CCN1-function abrogates the Tß4 effect. We further show that, in ischaemic rabbit hindlimbs, MRTF-A as well as Tß4 induce functional neovascularization, and that this process is inhibited by angiopoietin-2, which antagonizes pericyte recruitment. Moreover, MRTF-A improves contractile function of chronic hibernating myocardium of pigs to a level comparable to that of transgenic pigs overexpressing Tß4 (Tß4tg). We conclude that MRTF-A promotes microvessel growth (via CCN1) and maturation (via CCN2), thereby enabling functional improvement of ischaemic muscle tissue.

Original languageEnglish
Article number3970
JournalNature Communications
Volume5
DOIs
StatePublished - 9 Jun 2014
Externally publishedYes

Access to Document

Other files and links

Fingerprint

Dive into the research topics of 'MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2'. Together they form a unique fingerprint.

View full fingerprint

Cite this

  • APA
  • Author
  • BIBTEX
  • Harvard
  • Standard
  • RIS
  • Vancouver

Hinkel, R., Trenkwalder, T., Petersen, B., Husada, W., Gesenhues, F., Lee, S., Hannappel, E., Bock-Marquette, I., Theisen, D., Leitner, L., Boekstegers, P., Cierniewski, C., Müller, O. J., Le Noble, F., Adams, R. H., Weinl, C., Nordheim, A., Reichart, B., Weber, C., ... Kupatt, C. (2014). MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2. Nature Communications, 5, Article 3970. https://doi.org/10.1038/ncomms4970

Hinkel, Rabea ; Trenkwalder, Teresa ; Petersen, Björn et al. / MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2. In: Nature Communications. 2014 ; Vol. 5.

@article{09856427f4144887895891a2ce403eb2,

title = "MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2",

abstract = "Gradual occlusion of coronary arteries may result in reversible loss of cardiomyocyte function (hibernating myocardium), which is amenable to therapeutic neovascularization. The role of myocardin-related transcription factors (MRTFs) co-activating serum response factor (SRF) in this process is largely unknown. Here we show that forced MRTF-A expression induces CCN1 and CCN2 to promote capillary proliferation and pericyte recruitment, respectively. We demonstrate that, upon G-actin binding, thymosin {\ss}4 (T{\ss}4), induces MRTF translocation to the nucleus, SRF-activation and CCN1/2 transcription. In a murine ischaemic hindlimb model, MRTF-A or T{\ss}4 promotes neovascularization, whereas loss of MRTF-A/B or CCN1-function abrogates the T{\ss}4 effect. We further show that, in ischaemic rabbit hindlimbs, MRTF-A as well as T{\ss}4 induce functional neovascularization, and that this process is inhibited by angiopoietin-2, which antagonizes pericyte recruitment. Moreover, MRTF-A improves contractile function of chronic hibernating myocardium of pigs to a level comparable to that of transgenic pigs overexpressing T{\ss}4 (T{\ss}4tg). We conclude that MRTF-A promotes microvessel growth (via CCN1) and maturation (via CCN2), thereby enabling functional improvement of ischaemic muscle tissue.",

author = "Rabea Hinkel and Teresa Trenkwalder and Bj{\"o}rn Petersen and Wira Husada and Florian Gesenhues and Seungmin Lee and Ewald Hannappel and Ildiko Bock-Marquette and Daniel Theisen and Laura Leitner and Peter Boekstegers and Czeslaw Cierniewski and M{\"u}ller, {Oliver J.} and {Le Noble}, Ferdinand and Adams, {Ralf H.} and Christine Weinl and Alfred Nordheim and Bruno Reichart and Christian Weber and Eric Olson and Guido Posern and Elisabeth Deindl and Heiner Niemann and Christian Kupatt",

year = "2014",

month = jun,

day = "9",

doi = "10.1038/ncomms4970",

language = "English",

volume = "5",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Publishing Group",

}

Hinkel, R, Trenkwalder, T, Petersen, B, Husada, W, Gesenhues, F, Lee, S, Hannappel, E, Bock-Marquette, I, Theisen, D, Leitner, L, Boekstegers, P, Cierniewski, C, Müller, OJ, Le Noble, F, Adams, RH, Weinl, C, Nordheim, A, Reichart, B, Weber, C, Olson, E, Posern, G, Deindl, E, Niemann, H 2014, 'MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2', Nature Communications, vol. 5, 3970. https://doi.org/10.1038/ncomms4970

MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2. / Hinkel, Rabea; Trenkwalder, Teresa; Petersen, Björn et al.
In: Nature Communications, Vol. 5, 3970, 09.06.2014.

Research output: Contribution to journalArticlepeer-review

TY - JOUR

T1 - MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2

AU - Hinkel, Rabea

AU - Trenkwalder, Teresa

AU - Petersen, Björn

AU - Husada, Wira

AU - Gesenhues, Florian

AU - Lee, Seungmin

AU - Hannappel, Ewald

AU - Bock-Marquette, Ildiko

AU - Theisen, Daniel

AU - Leitner, Laura

AU - Boekstegers, Peter

AU - Cierniewski, Czeslaw

AU - Müller, Oliver J.

AU - Le Noble, Ferdinand

AU - Adams, Ralf H.

AU - Weinl, Christine

AU - Nordheim, Alfred

AU - Reichart, Bruno

AU - Weber, Christian

AU - Olson, Eric

AU - Posern, Guido

AU - Deindl, Elisabeth

AU - Niemann, Heiner

AU - Kupatt, Christian

PY - 2014/6/9

Y1 - 2014/6/9

N2 - Gradual occlusion of coronary arteries may result in reversible loss of cardiomyocyte function (hibernating myocardium), which is amenable to therapeutic neovascularization. The role of myocardin-related transcription factors (MRTFs) co-activating serum response factor (SRF) in this process is largely unknown. Here we show that forced MRTF-A expression induces CCN1 and CCN2 to promote capillary proliferation and pericyte recruitment, respectively. We demonstrate that, upon G-actin binding, thymosin ß4 (Tß4), induces MRTF translocation to the nucleus, SRF-activation and CCN1/2 transcription. In a murine ischaemic hindlimb model, MRTF-A or Tß4 promotes neovascularization, whereas loss of MRTF-A/B or CCN1-function abrogates the Tß4 effect. We further show that, in ischaemic rabbit hindlimbs, MRTF-A as well as Tß4 induce functional neovascularization, and that this process is inhibited by angiopoietin-2, which antagonizes pericyte recruitment. Moreover, MRTF-A improves contractile function of chronic hibernating myocardium of pigs to a level comparable to that of transgenic pigs overexpressing Tß4 (Tß4tg). We conclude that MRTF-A promotes microvessel growth (via CCN1) and maturation (via CCN2), thereby enabling functional improvement of ischaemic muscle tissue.

AB - Gradual occlusion of coronary arteries may result in reversible loss of cardiomyocyte function (hibernating myocardium), which is amenable to therapeutic neovascularization. The role of myocardin-related transcription factors (MRTFs) co-activating serum response factor (SRF) in this process is largely unknown. Here we show that forced MRTF-A expression induces CCN1 and CCN2 to promote capillary proliferation and pericyte recruitment, respectively. We demonstrate that, upon G-actin binding, thymosin ß4 (Tß4), induces MRTF translocation to the nucleus, SRF-activation and CCN1/2 transcription. In a murine ischaemic hindlimb model, MRTF-A or Tß4 promotes neovascularization, whereas loss of MRTF-A/B or CCN1-function abrogates the Tß4 effect. We further show that, in ischaemic rabbit hindlimbs, MRTF-A as well as Tß4 induce functional neovascularization, and that this process is inhibited by angiopoietin-2, which antagonizes pericyte recruitment. Moreover, MRTF-A improves contractile function of chronic hibernating myocardium of pigs to a level comparable to that of transgenic pigs overexpressing Tß4 (Tß4tg). We conclude that MRTF-A promotes microvessel growth (via CCN1) and maturation (via CCN2), thereby enabling functional improvement of ischaemic muscle tissue.

UR - http://www.scopus.com/inward/record.url?scp=84902248750&partnerID=8YFLogxK

U2 - 10.1038/ncomms4970

DO - 10.1038/ncomms4970

M3 - Article

C2 - 24910328

AN - SCOPUS:84902248750

SN - 2041-1723

VL - 5

JO - Nature Communications

JF - Nature Communications

M1 - 3970

ER -

Hinkel R, Trenkwalder T, Petersen B, Husada W, Gesenhues F, Lee S et al. MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2. Nature Communications. 2014 Jun 9;5:3970. doi: 10.1038/ncomms4970

MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2 (2024)

FAQs

What is the function of MRTF? ›

MRTF is an actin monomer- (G-actin) binding protein and its association with G-actin inhibits its nuclear accumulation. This is, in part, due to G-actin-mediated masking of MRTF's nuclear localization signal (NLS) [67] but also to the faster export of the MRTF/G-actin complex from the nucleus [68,69].

What is the MRTF pathway? ›

The MRTF-A/SRF pathway is activated in response to external cell stimuli which initiates F-actin polymerization downstream of RhoA activation. MRTF-A constantly shuttles between the cytoplasm and the nucleus but has been shown to be mainly cytoplasmic in resting cells.

What is the molecular weight of MRTF? ›

Molecular Weight of MRTF-A: 160 kDa. Positive Controls: Hep G2 cell lysate: sc-2227, HUV-EC-C whole cell lysate: sc-364180 or HeLa whole cell lysate: sc-2200.

What are the functions of coactivators? ›

Transcriptional coactivators have emerged as the principal regulators of gene expression by directly interacting with and modulating the activity of essentially all nuclear receptors (NRs) and transcription factors.

What is the GTF2I pathway? ›

Summaries for GTF2I Gene

Among its related pathways are RNA Polymerase II Transcription Initiation And Promoter Clearance and Akt Signaling. Gene Ontology (GO) annotations related to this gene include DNA-binding transcription factor activity and mitogen-activated protein kinase binding.

What is the function of the forkhead protein? ›

Forkhead box protein O1 (FoXO1) is a transcription factor involved in the regulation of a wide variety of physiological process including glucose metabolism, lipogenesis, bone mass, apoptosis, and autophagy.

What is the function of the GAL4 protein? ›

GAL4/UAS is a binary system with two main components: The yeast transcription factor GAL4 (expressed in a tissue and/or time-specific pattern) activates transgenes under the control of a UAS (upstream activating sequence) promoter, thus enabling spatiotemporal specific transgene expression.

References

Top Articles
Latest Posts
Article information

Author: Jamar Nader

Last Updated:

Views: 6106

Rating: 4.4 / 5 (55 voted)

Reviews: 94% of readers found this page helpful

Author information

Name: Jamar Nader

Birthday: 1995-02-28

Address: Apt. 536 6162 Reichel Greens, Port Zackaryside, CT 22682-9804

Phone: +9958384818317

Job: IT Representative

Hobby: Scrapbooking, Hiking, Hunting, Kite flying, Blacksmithing, Video gaming, Foraging

Introduction: My name is Jamar Nader, I am a fine, shiny, colorful, bright, nice, perfect, curious person who loves writing and wants to share my knowledge and understanding with you.